Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
about
Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq ConsortiumClinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Genomic sequencing in clinical practice: applications, challenges, and opportunities.Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis.Paradigm Shifts in Ophthalmic Diagnostics.Genetics of Disorders of Sex Development: The DSD-TRN Experience.Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes.The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.Implementing Personalized Medicine in the Academic Health Center.PLAZA 4.0: an integrative resource for functional, evolutionary and comparative plant genomics.Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort.The importance of genetic testing as demonstrated by two cases of CACNA1F-associated retinal generation misdiagnosed as LCA.Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.Genetic Test, Risk Prediction, and Counseling.Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data.Communication challenges for nongeneticist physicians relaying clinical genomic results.DECIDE: a Decision Support Tool to Facilitate Parents' Choices Regarding Genome-Wide Sequencing.Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes.Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough SolutionsSuccessful Adaptation of Targeted Gene Panel Next-Generation Sequencing in Regional Hospital in Hong Kong: Genomic Diagnosis of -Related Seizure DisorderEconomic evaluation of genomic sequencing in the paediatric population: a critical review
P2860
Q26749580-1539266A-A28B-4218-BC17-6642F023C505Q34526631-B80A0AB1-B0F8-4C74-97E9-EA69B22DFBB4Q37344774-7B01EEC2-6591-419A-8A8E-7227173AC28FQ37404690-252E32F0-B13A-4841-8ED9-4228B32A5D1CQ37480451-532DE5BB-818B-4CC7-B9CB-7EC1CC211C9DQ38370942-A6E1E834-33E5-41B2-AB75-CA6628EE59C2Q38987535-54D4ECA9-F2CD-470E-9C67-8E4B9E5DFB30Q39139865-0786B551-B403-4D4A-9C81-01C16C63CE70Q40445128-D1F9D176-77C5-4790-BE6E-436BFD011F44Q41590349-284D31F1-4486-4E3A-9A18-5A36951DCE3EQ42390010-245397E1-1B77-40B5-BC8A-53DE005F2E08Q46274918-5974F3AC-8B43-4914-8C5C-D1D597203E19Q46471388-92BED9B0-F81B-48F1-9627-04D5B48E9922Q47151151-1F54445F-29C4-4261-85FB-1ADB9165B61CQ47207156-580A6A49-FE71-4307-B15D-6F218DD7579AQ47650845-603D7DAB-BEB1-450B-9475-0DAEDA1EB691Q47945968-692F4FAB-B0D7-4793-8682-21F32A9F1F2CQ48267638-05AD694F-390E-4F91-BEC0-013C0EA6DE84Q48516627-F9CDBA20-42AA-44BA-8B0E-E67FC2FB56D8Q49584113-4327A68D-1A7C-4D24-8F20-0DBCE11DD3E9Q50510439-65873981-D8DA-44BE-A057-94088BA9833FQ52375104-641BD1CC-EB15-4137-982A-C3184BDCFC90Q57166342-5397E393-2D1B-4B5A-A7A8-83A26ACA5FC2Q57646585-C129C9B3-BA4E-4D26-97CD-82BBD3D71534Q58436879-BE63F7AD-CBEE-4734-8455-DC59B280DADF
P2860
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@ast
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@en
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@nl
type
label
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@ast
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@en
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@nl
prefLabel
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@ast
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@en
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@nl
P2860
P3181
P356
P1476
Assessing the Costs and Cost-Effectiveness of Genomic Sequencing
@en
P2093
Dmitry Dukhovny
Robert C Green
P2860
P304
P3181
P356
10.3390/JPM5040470
P407
P577
2015-01-01T00:00:00Z